Reimagining Code Status in the 80+ Population: Beyond ‘Full Code’ vs ‘DNR.’ Review Abstract The traditional binary approach to code status decisions in patients over 80 years old fails to address the complex medical and ethical considerations inherent in this vulnerable population. This paper examines
Tag: geriatric medicine
Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine
Immune Aging (Immunosenescence) The Next Major Target for Longevity Medicine Abstract The human immune system undergoes gradual decline with advancing age, a process termed immunosenescence. This deterioration represents one of the most promising targets for extending healthy lifespan. Research demonstrates that immune aging contributes to
Sarcopenia Clinics: Is It Time for a New Geriatric Subspecialty?
Sarcopenia Clinics Is It Time for a New Geriatric Subspecialty Abstract Sarcopenia has emerged as one of the most important age related musculoskeletal disorders in contemporary geriatric medicine. Characterized by progressive loss of skeletal muscle mass, reduced muscle strength, and impaired physical performance, sarcopenia contributes significantly to frailty, falls,
Muscle Aging and Sarcopenia: Are Senolytics the Missing Piece?
Muscle Aging and Sarcopenia: Are Senolytics the Missing Piece? Abstract Age-related muscle loss, known as sarcopenia, affects millions of older adults worldwide. This condition leads to decreased strength, mobility, and independence while increasing fall risk and mortality. Traditional treatments focus on exercise and
From Nursing Home to Hospital and Back: Are We Finally Fixing the Revolving Door?
De-prescribing in Older Adults: Why “Less is More” is Easier Said Than Done
